Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 104 clinical trials
Study of OT-101 in Treating Myopia

This is a phase III, randomized, double-masked, placebo-controlled, parallel-group, multicenter safety, tolerability, and efficacy study of atropine sulfate 0.01% (OT-101) as an investigational treatment for myopia in pediatric subjects

  • 97 views
  • 13 Aug, 2021
  • 7 locations
A Randomized Trial of Low-Dose Bevacizumab vs Laser for Type 1 ROP (ROP3)

prematurity (ROP). The study also will assess neurodevelopment, refractive error, visual acuity, and peripheral visual fields.

  • 0 views
  • 13 May, 2022
  • 8 locations
Maximizing the Initial Experience of a Neophyte Scleral Lens Wearer

The goal of this proposal is to conduct a randomized controlled study aimed at learning the best method for applying scleral lenses and factors associated with successfully completing scleral lens application and removal training.

  • 0 views
  • 14 May, 2022
  • 1 location
Superior vs Temporal Laser Peripheral Iridotomy in Primary Angle Closure Suspects (PACS)

Basic Study Design: Prospective, randomized, single-center, single-blinded study to compare dysphotopsias and pain recollection immediately 2 weeks, and 3 months after LPI in PACS patients who have a clear indication for bilateral LPI. Our null hypothesis is that there is no difference in dysphotopsia or pain levels by LPI position. …

Accepts healthy volunteers
  • 0 views
  • 15 May, 2022
  • 1 location
Village-Integrated Eye Worker Trial II - Pilot (VIEW II Pilot)

treatment. The leading causes of visual impairment are cataract and refractive error, followed by glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy (DR). Loss of vision from these

macular degeneration
bilateral cataracts
brimonidine tartrate ophthalmic solution
Accepts healthy volunteers
eye disease
  • 126 views
  • 04 Mar, 2022
  • 1 location
Providing Financial Incentives to Improve Adherence to Referral Eye Care Visits

Glaucoma is a blinding eye disease increasingly common in older adults, particularly in African Americans, and often diagnosed late in the disease course. It is essential to develop novel health care models, utilizing telemedicine, to improve the ability to detect glaucoma at an earlier stage, and to provide a platform …

diabetes
glaucoma
visual loss
Accepts healthy volunteers
eye disease
  • 0 views
  • 22 Apr, 2022
  • 1 location
Village-Integrated Eye Worker Trial II (VIEW II)

treatment. The leading causes of visual impairment are cataract and refractive error, followed by glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy (DR). Loss of vision from these

macular degeneration
brimonidine tartrate ophthalmic solution
Accepts healthy volunteers
eye disease
age-related macular degeneration
  • 42 views
  • 10 Feb, 2022
  • 1 location
Safety and Efficacy of Different Add Powers With a New Presbyopic Lasik Treatment Algorithm

This is a prospective, comparative, randomized, controlled, open-label, single-surgeon, single-center PMCF clinical study whereby presbyopic patients undergoing refractive surgery will receive a SUPRACOR treatment for the correction in the non-dominant eye and a PROSCAN refractive treatment in the dominant eye to correct for ametropia. The participants will be randomized to …

  • 4 views
  • 15 Mar, 2021
  • 1 location
Clinical Assessment of Two Daily Wear Reusable Soft Silicone Hydrogel Contact Lenses

The overall objective of this clinical study is to describe the clinical performance of the TOTAL30 soft contact lens compared to the ACUVUE OASYS with HYDRACLEAR PLUS (AOHP) soft contact lens in a daily wear modality.

  • 0 views
  • 21 Mar, 2022
  • 1 location
A Prospective, Multi-Center Evaluation of Corneal Flap Creation Using Cheetah Femtosecond Laser System and Cheetah Patient Interface

The study is a 2-phase, prospective, open-label, comparative (phase II) study design that was chosen for the purpose of optimizing the Cheetah settings (phase I), and evaluating the Cheetah system quality of LASIK flap (phase II).

  • 0 views
  • 01 May, 2022
  • 2 locations